Weill Cornell Medicine-Qatar awarded Cornell University medical degrees to 41 new doctors on May 11 during the college’s first graduation ceremony held in person since the beginning of the COVID-19 pandemic.
Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.
A team led by collaborating researchers from Weill Cornell Medicine, Weill Cornell Medicine—Qatar and Qatar Foundation have assembled a large genomic database on the Qatari people, and have used it to develop an advanced but low-cost screening tool for genetic diseases in this highly distinct Middle Eastern population.
Weill Cornell Medicine-Qatar welcomed 41 new doctors into the medical profession during commencement on May 5, bringing the total number of physicians educated by the institution to 463 since its inception in 2001.
The first and largest genetic association study in the Middle East revealed genetic variations that are specific to the Qatari population, a group of researchers at Qatar Foundation reported Feb. 23 in Nature Communications.
Medical students at Weill Cornell Medicine-Qatar (WCM-Q) have answered a call from the Ministry of Public Health (MOPH) for volunteers to help tackle the COVID-19 pandemic.
Weill Cornell Medicine–Qatar on May 6 celebrated the dedication and hard work of some of the world’s newest doctors as the Class of 2020 received their Cornell University medical degrees during commencement.
More than 370 students celebrated a milestone on May 30: graduating from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences and Weill Cornell Medicine-Qatar.
